Sign in

CIK 0001672688

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company
Ticker
ABSI
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Entity type
Operating
EIN
853383487
Phone
+1 360-949-1041
Business address
18105 SE MILL PLAIN BLVD, VANCOUVER, WA, 98683
Former names
AbSci, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-06-12 Redmile Group, LLC Director Grant or award +8,820 8,262,136
2024-06-12 Redmile Group, LLC Director Grant or award · Stock Option (Right to Buy) +36,274 36,274
2024-03-01 Redmile Group, LLC Director Purchase +222,222 $4.50 $1000K 8,253,316
2023-06-14 Redmile Group, LLC Director Grant or award · Stock Option (Right to Buy) +53,100 53,100
2022-06-08 Redmile Group, LLC Director Grant or award · Stock Option (Right to Buy) +28,700 28,700
2021-07-26 Redmile Group, LLC Director Conversion +4,209,573 4,209,573
2021-07-26 Redmile Group, LLC Director Conversion +1,946,521 6,156,094
2021-07-26 Redmile Group, LLC Director Purchase +1,875,000 $16.00 $30.0M 8,031,094
2021-07-26 Redmile Group, LLC Director Conversion · Series E Convertible Preferred Stock −4,209,573 0
2021-07-26 Redmile Group, LLC Director Conversion · Convertible Promissory Note −0 0

Page 1 of 1 · 10 trades